Benzinga's Top Upgrades
Analysts at Citigroup upgraded Rigel Pharmaceuticals Inc (NASDAQ: RIGL) from “neutral” to “buy.” RIGL's stock closed at $9.35 yesterday. Rigel Pharmaceuticals had $265.68 million in total cash for the recent quarter.
Analysts at Robert W. Baird upgraded URS Corporation (NYSE: URS) from “neutral” to “outperform.” URS' shares closed at $44.85 yesterday. URS' PEG ratio is 1.24.
Analysts at Bank of America upgraded DDR Corp. (NYSE: DDR) from “neutral” to “buy.” DDR's shares closed at $13.97 yesterday. DDR Corp. had $41.21 million in total cash for the recent quarter.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.